omega select 3-6-7-9 (2019.) kapsula
erba vita s.p.a. - kapsula
xeplion
janssen-cilag international n.v. - paliperidona palmitāts - Šizofrēnija - psihoterapija - xeplion ir indicēts šizofrēnijas ārstēšanai pieaugušiem pacientiem, kas stabilizēti ar paliperidonu vai risperidonu. in selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate and a long-acting injectable treatment is needed.
memantine lek
pharmathen s.a. - memantīna hidrohlorīds - alcheimera slimība - psychoanaleptics, , citas anti-demenci zāles - pacientiem ar vidēji smagu vai smagu alcheimera slimību ārstēšana.
dozuril
dopharma research b.v., nīderlande - toltrazurils - šķīdums lietošanai ar dzeramo ūdeni - 25 mg/ml - vistas
rivaroxaban auxilia 2,5 mg apvalkotās tabletes
auxilia pharma oÜ, estonia - rivaroksabans - apvalkotā tablete - 2,5 mg
xarelto
bayer ag - rivaroxaban - arthroplasty, replacement; venous thromboembolism - antitrombotiskie līdzekļi - xarelto, co-ievadīts ar acetilsalicilskābi (asa) atsevišķi vai kopā ar asa plus klopidogrelu vai ticlopidine, ir norādīts, lai novērstu atherothrombotic notikumiem pieaugušiem pacientiem pēc akūta koronāra sindroma (acs) ar paaugstinātu sirds izmeklējumus. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. venozās trombembolijas (vte) profilakse pieaugušiem pacientiem, kuriem tiek veikta gēnu vai ceļa locītavas locītavas operācija. Ārstēšana ar dziļo vēnu tromboze (dvt) un plaušu embolija (pe), un novērst atkārtotu dvt un pe pieaugušajiem. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
runaplax 15 mg apvalkotās tabletes
sandoz d.d., slovenia - rivaroksabans - apvalkotā tablete - 15 mg
runaplax 10 mg apvalkotās tabletes
sandoz d.d., slovenia - rivaroksabans - apvalkotā tablete - 10 mg
runaplax 20 mg apvalkotās tabletes
sandoz d.d., slovenia - rivaroksabans - apvalkotā tablete - 20 mg
rivaroxaban g.l. pharma 10 mg apvalkotās tabletes
g.l. pharma gmbh, austria - rivaroksabans - apvalkotā tablete - 10 mg